Get started
Author

David C. D. Hope

Observed names: D. C. D. Hope, D.C.D. Hope, DAVID HOPE, David C D Hope, David C.D. Hope, David CD Hope, David CD. Hope, David Hope
Observed institutions: AstraZeneca (United Kingdom), Imperial College Healthcare NHS Trust, King's College London, Chelsea and Westminster Hospital NHS Foundation Trust, Chelsea and Westminster Hospital, Imperial College London
ORCID: 0000-0002-0240-0687
Observed ORCID: 0000-0002-0240-0687
OpenAlex ID: A5020650223
Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study
2019 · Preeshila Behary, George Tharakan, et al. · Diabetes Care · 110
Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity
2021 · David C. D. Hope, Matthew L. Vincent, et al. · Frontiers in Endocrinology · 80
PDF
Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals
2021 · Chioma Izzi-Engbeaya, Walter Distaso, et al. · BMJ Open Diabetes Research & Care · 73
PDF
Hypoaminoacidemia underpins glucagon-mediated energy expenditure and weight loss
2022 · David C.D. Hope, Charlotte E. Hinds, et al. · Cell Reports Medicine · 32
PDF
No Guts, No Loss: Toward the Ideal Treatment for Obesity in the Twenty-First Century
2018 · David C. D. Hope, Tricia M. M. Tan, et al. · Frontiers in Endocrinology · 29
PDF
Effect of high‐fat diet on glucose homeostasis and gene expression in glucokinase knockout mice
2007 · T. Gorman, D. C. D. Hope, et al. · Diabetes Obesity and Metabolism · 29
Skeletal muscle loss and sarcopenia in obesity pharmacotherapy
2024 · David C. D. Hope, Tricia M-M Tan · Nature Reviews Endocrinology · 22
Glucagon and energy expenditure; Revisiting amino acid metabolism and implications for weight loss therapy
2023 · D.C.D. Hope, T.M-M. Tan · Peptides · 16
Sleeve gastrectomy causes weight‐loss independent improvements in hepatic steatosis
2023 · Emma Rose McGlone, Matthieu Siebert, et al. · Liver International · 13
PDF
A glucagon analogue decreases body weight in mice via signalling in the liver
2021 · Charlotte E. Hinds, Bryn M. Owen, et al. · Scientific Reports · 13
PDF
Assembly of bioactive multilayered nanocoatings on pancreatic islet cells: incorporation of α1-antitrypsin into the coatings
2015 · Zheng-Liang Zhi, Jashandeep Singh, et al. · Chemical Communications · 13
Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity
2024 · Emma Rose McGlone, David C.D. Hope, et al. · Biomedicine & Pharmacotherapy · 11
Adaptive infusion of a glucagon‐like peptide‐1/glucagon receptor co‐agonist G3215 , in adults with overweight or obesity: Results from a phase 1 randomized clinical trial
2024 · David C. D. Hope, Saleem Ansari, et al. · Diabetes Obesity and Metabolism · 6
PDF
Interventions for the prevention and management of cardiometabolic multiple long-term conditions
2026 · Jonathan Valabhji, David Hope, et al. · The Lancet · 5
Association between the English National Health Service Diabetes Prevention Programme and incident multiple long-term conditions
2025 · Emma Barron, Paul Chappell, et al. · Nature Medicine · 5
PDF
Dietary protein defends lean mass and maintains the metabolic benefits of glucagon receptor agonism in mice
2024 · Tatiana Lopes, David CD. Hope, et al. · Molecular Metabolism · 3
SGLT2 inhibitors and dietary calorie restriction for type 2 diabetes remission
2025 · David Hope, Jonathan Valabhji · BMJ · 2
57-OR: Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Glycaemia and Body Weight in Obesity and Type 2 Diabetes: A Randomized, Single-Blinded Study
2019 · PREESHILA BEHARY, GEORGE THARAKAN, et al. · Diabetes · 1
Diabetic peripheral neuropathy: the broader complication burden
2026 · Jonathan Valabhji, Aikaterini Theodoraki, et al. · BMJ
When calcium tells a deeper story: a case of atypical parathyroid adenoma with malignant features
2026 · Jenifar Prashanthan, David Hope, et al. · Endocrine Abstracts
Challenges in management and pharmacotherapeutic strategy in patients with a prolactinoma and neuropsychosis; a case presentation and literature review
2020 · Ahmad Moolla, David Hope, et al. · Endocrine Abstracts
GLP-1/Glucagon dual agonist affects amino acid metabolism
2019 · Rebecca Scott, David Hope, et al. · Endocrine Abstracts
The differential effects of weight loss by RYGB versus very-low calorie diet (VLCD) on gut hormone levels and appetite: potential contribution to sustained weight loss
2019 · Preeshila Behary, George Tharakan, et al. · Endocrine Abstracts
Metabolic changes post Roux-En-Y Gastric Bypass: one year prospective study
2019 · Kleopatra Alexiadou, Preeshila Behary, et al. · Endocrine Abstracts
A case of respiratory arrest associated with sepsis induced myxoedema coma
2018 · Edson Nogueira, Kyaw Khin, et al. · Endocrine Abstracts
Works count: 26
Citation count: 462
H-index: 11
I10-index: 12
Year
Topic
Type